Individual long-term albuminuria exposure during angiotensin receptor blocker therapy is the optimal predictor for renal outcome
Conclusions
Following the initial response to ARBs, a large within-patient albuminuria variability is observed. Hence, incorporating multiple albuminuria measurements over time in risk algorithms may be more appropriate to monitor treatment effects and quantify renal risk.
Source: Nephrology Dialysis Transplantation - Category: Urology & Nephrology Authors: Felix Kröpelin, T., de Zeeuw, D., Holtkamp, F. A., Packham, D. K., L. Heerspink, H. J. Tags: Chronic Kidney Disease Source Type: research
More News: Avapro | Chronic Kidney Disease | Cozaar | Diabetes | Dialysis | Endocrinology | Kidney Transplant | Kidney Transplantation | Losartan | Study | Transplants | Urology & Nephrology